Onderneming Novus Therapeutics, Inc. Nasdaq
Aandelen
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 01-05-20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15-03-21 |
Steven Perrin
PSD | President | 59 | 14-09-20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-22 |
Bryan Smith
CMP | Compliance Officer | 45 | 19-04-21 |
David Hovland
LAW | General Counsel | - | 19-04-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01-05-17 |
Walter Ogier
BRD | Director/Board Member | 67 | 14-09-20 |
John McBride
BRD | Director/Board Member | 72 | 01-05-17 |
Steven Perrin
PSD | President | 59 | 14-09-20 |
Chief Executive Officer | 51 | 01-05-20 | |
James Robinson
BRD | Director/Board Member | 54 | 01-10-23 |
June Lee
BRD | Director/Board Member | 58 | 09-12-20 |
Jan Hillson
BRD | Director/Board Member | 71 | 02-07-21 |
Allan Kirk
BRD | Director/Board Member | 62 | 02-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 110 086 | 0 | 0 | 96,49 % |
Aandeel B | 1 | 38 506 614 | 37 155 255 ( 96,49 %) | 0 | |
Aandeel C | 0 | 4 422 | 0 | 0 |
Bedrijfsgegevens
![Adres Novus Therapeutics, Inc.](https://cdn.zonebourse.com/static/address/34879319.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,13% | 122 mld. | |
+19,65% | 115 mld. | |
+21,22% | 26,64 mld. | |
-23,84% | 19,91 mld. | |
-17,47% | 16,32 mld. | |
-45,95% | 15,52 mld. | |
-19,28% | 15,49 mld. | |
+63,81% | 14,83 mld. | |
+1,94% | 13,67 mld. |